LncRNA FBXO18-AS Promotes Gastric Cancer Progression by TGF-β1/Smad Signaling

Overview

Journal Eur J Histochem

Specialty Biochemistry

Date 2023 Jun 21

PMID 37340903

Authors

Yiming Zhang

Wanqiong Zheng

Liang Zhang

Yechun Gu

Lihe Zhu

Yingpeng Huang

Affiliations

Soon will be listed here.

Abstract

For the digestive system, there exists one common malignant tumor, known as gastric cancer. It is the third most prevalent type of tumor among different tumors worldwide. It has been reported that long noncoding RNAs (lncRNAs), participate in various biological processes of gastric cancer. However, there are still many lncRNAs with unknown functions, and we discovered a novel lncRNA designated as FBXO18-AS. Whether lncRNAFBXO18-AS participates in gastric cancer progression is still unknown. Bioinformatic analysis, immunohistochemistry, Western blotting, and qPCR were carried out to explore FBXO18-AS and TGF-β1 expression. In addition, EdU, MTS, migration and transwell assays were performed to investigate the invasion, proliferation and migration of gastric cancer in vitro. We first discovered that FBXO18-AS expression was upregulated in gastric cancer and linked to poorer outcomes among patients with gastric cancer. Then, we confirmed that FBXO18-AS promoted the proliferation, invasion, migration, and an EMT-like process in gastric cancer in vivo and in vitro. Mechanistically, FBXO18-AS was found to be involved in the progression of gastric cancer by modulating TGF-β1/Smad signaling. Therefore, it might offer a possible biomarker for gastric cancer diagnosis and an effective strategy for clinical treatment.

Citing Articles

Heparan sulfate 6-O-sulfotransferase 2 promotes gastric cancer progression by modulating the TGF-β/smad2/3 pathway.

Wu S, Xu C, Sun W, Xu Q, Zhou F, Jia R Am J Transl Res. 2025; 16(12):7924-7936.

PMID: 39822499 PMC: 11733364. DOI: 10.62347/LWZR1836.

lncRNA WAC-AS1 promotes the progression of gastric cancer through miR-204-5p/HOXC8 axis.

Liu Y, Li K, Gao Y, Feng Y, Zhao X, Hou R Transl Oncol. 2024; 50():102139.

PMID: 39395273 PMC: 11736402. DOI: 10.1016/j.tranon.2024.102139.

High expression of ABL2 promotes gastric cancer cells migration, invasion and proliferation via the TGF-β and YAP signaling pathways.

Liu Y, Jin T, Chen R, Miao R, Zhou Y, Shao S J Cancer. 2024; 15(17):5719-5728.

PMID: 39308677 PMC: 11414612. DOI: 10.7150/jca.99307.

VEGFA contributes to tumor property of glioblastoma cells by promoting differentiation of myeloid-derived suppressor cells.

Tian Y, Gao X, Yang X, Chen S, Ren Y BMC Cancer. 2024; 24(1):1040.

PMID: 39174921 PMC: 11342494. DOI: 10.1186/s12885-024-12803-8.

Non-Coding RNA as Biomarkers and Their Role in the Pathogenesis of Gastric Cancer-A Narrative Review.

Bakinowska E, Kielbowski K, Skorka P, Dach A, Olejnik-Wojciechowska J, Szwedkowicz A Int J Mol Sci. 2024; 25(10).

PMID: 38791187 PMC: 11121563. DOI: 10.3390/ijms25105144.

References

Feng W, Ding Y, Zong W, Ju S . Non-coding RNAs in regulating gastric cancer metastasis. Clin Chim Acta. 2019; 496:125-133. DOI: 10.1016/j.cca.2019.07.003. View

Xu W, He L, Li Y, Tan Y, Zhang F, Xu H . Silencing of lncRNA ZFAS1 inhibits malignancies by blocking Wnt/β-catenin signaling in gastric cancer cells. Biosci Biotechnol Biochem. 2018; 82(3):456-465. DOI: 10.1080/09168451.2018.1431518. View

Zhang F, Li Y, Xu W, He L, Tan Y, Xu H . Long non-coding RNA ZFAS1 regulates the malignant progression of gastric cancer via the microRNA-200b-3p/Wnt1 axis. Biosci Biotechnol Biochem. 2019; 83(7):1289-1299. DOI: 10.1080/09168451.2019.1606697. View

YiRen H, Yingcong Y, Sunwu Y, Keqin L, Xiaochun T, Senrui C . Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer. Mol Cancer. 2017; 16(1):174. PMC: 5699172. DOI: 10.1186/s12943-017-0743-3. View

Qi X, Zhang D, Wu N, Xiao J, Wang X, Ma W . ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015; 52(10):710-8. DOI: 10.1136/jmedgenet-2015-103334. View

Peng Z, Wang C, Fang E, Wang G, Tong Q . Role of epithelial-mesenchymal transition in gastric cancer initiation and progression. World J Gastroenterol. 2014; 20(18):5403-10. PMC: 4017055. DOI: 10.3748/wjg.v20.i18.5403. View

Jiang Y, Han S, Cheng W, Wang Z, Wu A . NFAT1-regulated IL6 signalling contributes to aggressive phenotypes of glioma. Cell Commun Signal. 2017; 15(1):54. PMC: 5735798. DOI: 10.1186/s12964-017-0210-1. View

Chen S, Dai J, Wang W, Ren C . LINC01857 promotes the proliferation, migration, and invasion of gastric cancer cells via regulating miR-4731-5p/HOXC6. Can J Physiol Pharmacol. 2022; 100(7):689-701. DOI: 10.1139/cjpp-2021-0411. View

Ghafouri-Fard S, Taheri M . Long non-coding RNA signature in gastric cancer. Exp Mol Pathol. 2020; 113:104365. DOI: 10.1016/j.yexmp.2019.104365. View

10.

Smyth E, Nilsson M, Grabsch H, van Grieken N, Lordick F . Gastric cancer. Lancet. 2020; 396(10251):635-648. DOI: 10.1016/S0140-6736(20)31288-5. View

11.

Guo Z, Li G, Bian E, Ma C, Wan J, Zhao B . TGF-β-mediated repression of MST1 by DNMT1 promotes glioma malignancy. Biomed Pharmacother. 2017; 94:774-780. DOI: 10.1016/j.biopha.2017.07.081. View

12.

Ye Y, Yang S, Han Y, Sun J, Xv L, Wu L . HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2. Open Biol. 2019; 9(9):190068. PMC: 6769292. DOI: 10.1098/rsob.190068. View

13.

Chen M, Wu X, Ma W, Zhou Q, Wang X, Zhang R . Decreased expression of lncRNA VPS9D1-AS1 in gastric cancer and its clinical significance. Cancer Biomark. 2017; 21(1):23-28. DOI: 10.3233/CBM-170172. View

14.

Zhang P, Chen C, Zhang J, Yu X . LncRNA CRYM-AS1 Inhibits Gastric Cancer Progression via Epigenetically Regulating CRYM. Ann Clin Lab Sci. 2022; 52(2):249-259. View

15.

Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv L . Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer. 2020; 19(1):62. PMC: 7081551. DOI: 10.1186/s12943-020-01185-7. View

16.

Li Z, Lu M, Zhou Y, Xu L, Jiang Y, Liu Y . Role of Long Non-Coding RNAs in the Chemoresistance of Gastric Cancer: A Systematic Review. Onco Targets Ther. 2021; 14:503-518. PMC: 7822221. DOI: 10.2147/OTT.S294378. View

17.

Chen H, Guan R, Lei Y, Chen J, Ge Q, Zhang X . Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis. BMC Cancer. 2015; 15:103. PMC: 4358729. DOI: 10.1186/s12885-015-1109-0. View

18.

Jiang Y, Zhou J, Luo P, Gao H, Ma Y, Chen Y . Prosaposin promotes the proliferation and tumorigenesis of glioma through toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway. EBioMedicine. 2018; 37:78-90. PMC: 6286187. DOI: 10.1016/j.ebiom.2018.10.053. View

19.

Jiang Y, Zhou J, Zhao J, Hou D, Zhang H, Li L . MiR-18a-downregulated RORA inhibits the proliferation and tumorigenesis of glioma using the TNF-α-mediated NF-κB signaling pathway. EBioMedicine. 2020; 52:102651. PMC: 7016377. DOI: 10.1016/j.ebiom.2020.102651. View

20.

Guo Y, Yue P, Wang Y, Chen G, Li Y . PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis. Biomed Pharmacother. 2019; 118:109255. DOI: 10.1016/j.biopha.2019.109255. View